SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey Boggis who wrote (359)4/4/1999 10:33:00 PM
From: virginijus poshkus  Read Replies (2) | Respond to of 550
 
Jeff, we are getting closer to the "orphan drug" category. i can easily see treating 1mm patients a year, at $10,000 a piece it will add up fast. no doubt we have the ammunition, enmd is along way off, and soon we will hit the target. $100 per share is not out of the question here, imho. we are talking about saving lives here, remember every cancer patient at one time or another enters the terminal phase.

vargas


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News